Shopping Cart
Remove All
Your shopping cart is currently empty
Anti-TNBC agent-10 is an agent targeting triple-negative breast cancer (TNBC). It demonstrates potent anti-TNBC activity against BT549 cells with an IC50 of 0.018 μM and remains active in MDA-MB-231 cells with an IC50 of 4.16 μM. In mice with subcutaneous MDA-MB-231 TNBC xenografts, it shows significant antitumor efficacy. Anti-TNBC agent-10 is applicable in TNBC studies.


| Description | Anti-TNBC agent-10 is an agent targeting triple-negative breast cancer (TNBC). It demonstrates potent anti-TNBC activity against BT549 cells with an IC50 of 0.018 μM and remains active in MDA-MB-231 cells with an IC50 of 4.16 μM. In mice with subcutaneous MDA-MB-231 TNBC xenografts, it shows significant antitumor efficacy. Anti-TNBC agent-10 is applicable in TNBC studies. |
| In vivo | As an anti-TNBC agent, Analog 9 (25 mg/kg, intraperitoneal injection, once daily for 5 consecutive days [Q1Dx5], over a period of 2 weeks) demonstrated significant antitumor efficacy in athymic nude mice bearing subcutaneous MDA-MB-231 TNBC xenografts. |
| Molecular Weight | 337.23 |
| Formula | C11H11F4N5O3 |
| Cas No. | 2923722-02-3 |
| Storage | Powder: -20°C for 3 years | In solvent: -80°C for 1 year | Shipping with blue ice/Shipping at ambient temperature. |
| Size | Quantity | Unit Price | Amount | Operation |
|---|

Copyright © 2015-2025 TargetMol Chemicals Inc. All Rights Reserved.